We are live on ! Find out more
OMC

Overbrook Management Corp Portfolio holdings

AUM $663M
1-Year Est. Return 35.04%
This Fund
S&P 500
This Quarter Est. Return
-1.87%
1 Year Est. Return
+35.04%
3 Year Est. Return
+145.9%
5 Year Est. Return
+162.55%
10 Year Est. Return
+621.18%
AUM
$430M
AUM Growth
+$8.6M
Cap. Flow
+$21.4M
Cap. Flow %
4.99%
Top 10 Hldgs %
55.17%
Holding
70
New
2
Increased
10
Reduced
35
Closed
6

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$12.4M
2
MTCH icon
Match Group
MTCH
+$11.7M
3
V icon
Visa
V
+$5.68M
4
KEYS icon
Keysight
KEYS
+$5.07M
5
INTU icon
Intuit
INTU
+$4.42M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$7.57M
2
GS icon
Goldman Sachs
GS
+$2.83M
3
JNJ icon
Johnson & Johnson
JNJ
+$1.58M
4
DAR icon
Darling Ingredients
DAR
+$1.34M
5
UNH icon
UnitedHealth
UNH
+$1.31M

Sector Composition

Rank Sector Weight
1 Technology 38.46%
2 Financials 20.13%
3 Communication Services 15.79%
4 Healthcare 11.72%
5 Consumer Discretionary 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MS icon
51
Morgan Stanley
MS
$337B
$307K 0.07%
3,764
– –
BMY icon
52
Bristol-Myers Squibb
BMY
$136B
$307K 0.07%
5,290
-50
-0.9% -$3.06K
CSBR icon
53
Champions Oncology
CSBR
$68.5M
$301K 0.07%
48,488
– –
MCD icon
54
McDonald's
MCD
$188B
$290K 0.07%
1,100
– –
GLD icon
55
SPDR Gold Trust
GLD
$149B
$260K 0.06%
1,515
– –
BSV icon
56
Vanguard Short-Term Bond ETF
BSV
$45.6B
$222K 0.05%
2,949
– –
GE icon
57
GE Aerospace
GE
$355B
$214K 0.05%
2,428
-126
-5% -$11.3K
CLDX icon
58
Celldex Therapeutics
CLDX
$3.07B
$210K 0.05%
7,644
-119
-2% -$3.73K
ADBE icon
59
Adobe
ADBE
$116B
$204K 0.05%
+400
New +$210K
ICCC icon
60
ImmuCell
ICCC
$90.3M
$175K 0.04%
32,857
– –
IA
61
Innovative Solutions & Support
IA
$370M
$111K 0.03%
14,575
– –
FF icon
62
Future Fuel
FF
$234M
$83.2K 0.02%
11,598
-53,602
-82% -$439K
INAB icon
63
IN8bio
INAB
$10.2M
$35.1K 0.01%
1,125
– –
STRM
64
DELISTED
Streamline Health Solutions
STRM
$27.8K 0.01%
1,917
– –
PEP icon
65
PepsiCo
PEP
$193B
– –
-1,431
Closed -$265K
PFE icon
66
Pfizer
PFE
$159B
– –
-6,852
Closed -$251K
PG icon
67
Procter & Gamble
PG
$334B
– –
-1,756
Closed -$266K
POCI icon
68
Precision Optics
POCI
$48.2M
– –
-32,704
Closed -$201K
VTV icon
69
Vanguard Morningstar Value ETF
VTV
$192B
– –
-1,756
Closed -$250K
ISEE
70
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-15,000
Closed -$590K
1 2
3

Similar funds

BCP
Bain Capital Prairie Boston, Massachusetts $663M AUM
WA
WFM Asia Road Town, Tortola, British Virgin Islands $663M AUM 15.46% 1-Year Est. Return
WCP
Wick Capital Partners Wayne, Pennsylvania $663M AUM 22.39% 1-Year Est. Return
PCWA
Pacific Capital Wealth Advisors Corona, California $663M AUM 14.61% 1-Year Est. Return
CGIM
Capital Group Investment Management Raffles Quay, Singapore $664M AUM 34.11% 1-Year Est. Return
DS
Dudley & Shanley Palm Beach, Florida $662M AUM 10.7% 1-Year Est. Return
BMWS
Brady Martz Wealth Solutions Grand Forks, North Dakota $662M AUM 22.48% 1-Year Est. Return
MC
McMorgan & Co San Francisco, California $664M AUM 11.57% 1-Year Est. Return

Overbrook Management Corp's Q3 2023 Portfolio in Review

As of Q3 2023, Overbrook Management Corp held 70 positions worth $430M, up 2% from $421M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Overbrook Management Corp deployed $21.4M of net new capital in Q3 2023, opening 2 new positions and adding to 10 existing holdings. Its largest new stake was Match Group: 264,006 shares worth $10.3M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 37% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Royalty Pharma, an estimated $7.57M trimmed.

  • Overbrook Management Corp's largest Q3 2023 buy was Match Group: 264,006 shares worth $10.3M.
  • Overbrook Management Corp added most to NVIDIA in Q3 2023, an estimated $12.4M increase.
  • Overbrook Management Corp's biggest Q3 2023 reduction was Royalty Pharma, cutting an estimated $7.57M.
  • Overbrook Management Corp fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $590K.
  • Overbrook Management Corp's ten largest holdings make up 55% of its $430M portfolio in Q3 2023.
  • Overbrook Management Corp opened 2 new positions and closed 6 in Q3 2023.
  • Overbrook Management Corp's portfolio value rose 2% quarter-over-quarter to $430M.

Based on Overbrook Management Corp's 13F filing for Q3 2023, filed 13 Nov 2023.